Back to results

Ludwig-Maximilians-Universität

Ex-vivo Untersuchungen zur Arzneimittelwirkung topischer Tacrolimus (FK-506) Anwendung auf epidermale dendritische Zellen in läsionaler Haut bei Patienten mit atopischem Ekzem

Abstract

dc:description.abstract

Topical tacrolimus (FK506) leads to profound phenotypic and functional alterations of epidermal antigen-presenting dendritic cells in atopic dermatitis. BACKGROUND: Atopic dermatitis (AD) is a chronic inflammatory skin disease in which antigen-presenting epidermal dendritic cells (DCs), ie, Langerhans cells and the so-called inflammatory dendritic epidermal cells (IDECs) expressing the high-affinity receptor for IgE (FcepsilonRI) may play a significant pathophysiologic role. Therapeutic efficacy of the immunosuppressive macrolide tacrolimus (FK506) in AD has been demonstrated in clinical trials, but little is known of its mode of action. OBJECTIVE: The present study focused on the effects of topical tacrolimus treatment on epidermal CD1a+/FcepsilonRI+ DC populations in lesional AD. METHODS: Immunohistological analysis, epidermal DC phenotyping, and functional studies were performed on skin biopsy specimens from treated and untreated lesional skin of 10 patients with AD participating in a clinical trial with tacrolimus. RESULTS: Untreated lesional skin was characterized by a high proportion of CD1a+ cells, which was largely due to a high proportion of IDECs strongly expressing FcepsilonRI. Epidermal DCs isolated from untreated lesional skin exhibited high stimulatory activity toward autologous T cells, which was strongly reduced while clinical improvement was seen during application of tacrolimus. Concomitantly, a decreased FcepsilonRI expression was observed in both Langerhans cells and IDECs. Finally, topical tacrolimus led to a progressive decrease in the IDEC population within the pool of CD1a+ epidermal DCs and also to a decrease in their CD36 expression, which is indicative of lower local inflammation. CONCLUSION: Epidermal CD1a+ DCs may represent a target for topical tacrolimus in the treatment of AD.

Degree

thesis:*
Level thesis:degree_level
thesis.doctoral
Grantor dc:publisher
Ludwig-Maximilians-Universität
Year
2004

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Sharma, Sheena

Identifiers

dc:identifier.*
Repository record source_url
https://edoc.ub.uni-muenchen.de/1713/
OAI identifier oai:identifier
oai:edoc.ub.uni-muenchen.de:1713

Chain of custody

source
Harvested from
Ludwig Maxmilians Universität München
Base URL
edoc.ub.uni-muenchen.de/cgi/oai2
Last updated
2026-07-24
Source record
OAI-PMH GetRecord
citation

Sharma, Sheena. Ex-vivo Untersuchungen zur Arzneimittelwirkung topischer Tacrolimus (FK-506) Anwendung auf epidermale dendritische Zellen in läsionaler Haut bei Patienten mit atopischem Ekzem. thesis.doctoral thesis, Ludwig-Maximilians-Universität, 2004. https://edoc.ub.uni-muenchen.de/1713/